10x Genomics, Inc.

NasdaqGS:TXG 주식 보고서

시가총액: US$2.4b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

10x Genomics 관리

관리 기준 확인 3/4

10x Genomics' CEO는 Serge Saxonov, Jul2012 에 임명되었습니다 의 임기는 11.92 년입니다. 총 연간 보상은 $ 8.29M, 6.6% 로 구성됩니다. 6.6% 급여 및 93.4% 보너스(회사 주식 및 옵션 포함). 는 $ 79.46M 가치에 해당하는 회사 주식의 3.36% 직접 소유합니다. 79.46M. 경영진과 이사회의 평균 재임 기간은 각각 6.3 년과 6.8 년입니다.

주요 정보

Serge Saxonov

최고 경영자

US$8.3m

총 보상

CEO 급여 비율6.6%
CEO 임기11.9yrs
CEO 소유권3.4%
경영진 평균 재임 기간6.3yrs
이사회 평균 재임 기간6.8yrs

최근 관리 업데이트

Recent updates

10x Genomics: Sticking To The Plan To Avoid The Falling The Knife

Jun 21

Take Care Before Jumping Onto 10x Genomics, Inc. (NASDAQ:TXG) Even Though It's 26% Cheaper

Jun 14
Take Care Before Jumping Onto 10x Genomics, Inc. (NASDAQ:TXG) Even Though It's 26% Cheaper

10x Genomics (NASDAQ:TXG) Is In A Strong Position To Grow Its Business

May 21
10x Genomics (NASDAQ:TXG) Is In A Strong Position To Grow Its Business

Why We're Not Concerned About 10x Genomics, Inc.'s (NASDAQ:TXG) Share Price

Apr 15
Why We're Not Concerned About 10x Genomics, Inc.'s (NASDAQ:TXG) Share Price

Here's Why We're Not Too Worried About 10x Genomics' (NASDAQ:TXG) Cash Burn Situation

Feb 05
Here's Why We're Not Too Worried About 10x Genomics' (NASDAQ:TXG) Cash Burn Situation

10x Genomics: Sales Are Growing At A Rapid Rate, But So Are Expenses

Jan 20

Revenues Tell The Story For 10x Genomics, Inc. (NASDAQ:TXG) As Its Stock Soars 31%

Dec 22
Revenues Tell The Story For 10x Genomics, Inc. (NASDAQ:TXG) As Its Stock Soars 31%

We're Hopeful That 10x Genomics (NASDAQ:TXG) Will Use Its Cash Wisely

Nov 03
We're Hopeful That 10x Genomics (NASDAQ:TXG) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About 10x Genomics' (NASDAQ:TXG) Cash Burn Situation

Aug 04
Here's Why We're Not Too Worried About 10x Genomics' (NASDAQ:TXG) Cash Burn Situation

Why Investors Shouldn't Be Surprised By 10x Genomics, Inc.'s (NASDAQ:TXG) P/S

Jun 04
Why Investors Shouldn't Be Surprised By 10x Genomics, Inc.'s (NASDAQ:TXG) P/S

At US$52.43, Is 10x Genomics, Inc. (NASDAQ:TXG) Worth Looking At Closely?

Apr 29
At US$52.43, Is 10x Genomics, Inc. (NASDAQ:TXG) Worth Looking At Closely?

10x Genomics, Inc. (NASDAQ:TXG) Shares Could Be 28% Below Their Intrinsic Value Estimate

Mar 24
10x Genomics, Inc. (NASDAQ:TXG) Shares Could Be 28% Below Their Intrinsic Value Estimate

We're Interested To See How 10x Genomics (NASDAQ:TXG) Uses Its Cash Hoard To Grow

Feb 02
We're Interested To See How 10x Genomics (NASDAQ:TXG) Uses Its Cash Hoard To Grow

Is Now The Time To Look At Buying 10x Genomics, Inc. (NASDAQ:TXG)?

Jan 12
Is Now The Time To Look At Buying 10x Genomics, Inc. (NASDAQ:TXG)?

An Intrinsic Calculation For 10x Genomics, Inc. (NASDAQ:TXG) Suggests It's 39% Undervalued

Dec 22
An Intrinsic Calculation For 10x Genomics, Inc. (NASDAQ:TXG) Suggests It's 39% Undervalued

10x Genomics: No Signs Of A Growth Turnaround, Heavy Bearish Momentum

Oct 12

Here's Why We're Not Too Worried About 10x Genomics' (NASDAQ:TXG) Cash Burn Situation

Oct 05
Here's Why We're Not Too Worried About 10x Genomics' (NASDAQ:TXG) Cash Burn Situation

10x Genomics cut to Sell at Goldman Sachs on slower sales ramp

Aug 18

10x Genomics: Still Expensive, No Profitability In Sight, And Insiders Are Still Selling

Jul 30

CEO 보상 분석

Serge Saxonov 의 보수는 10x Genomics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-US$264m

Dec 31 2023US$8mUS$545k

-US$255m

Sep 30 2023n/an/a

-US$223m

Jun 30 2023n/an/a

-US$172m

Mar 31 2023n/an/a

-US$174m

Dec 31 2022US$19mUS$504k

-US$166m

Sep 30 2022n/an/a

-US$167m

Jun 30 2022n/an/a

-US$142m

Mar 31 2022n/an/a

-US$89m

Dec 31 2021US$12mUS$430k

-US$58m

Sep 30 2021n/an/a

-US$455m

Jun 30 2021n/an/a

-US$504m

Mar 31 2021n/an/a

-US$533m

Dec 31 2020US$11mUS$400k

-US$543m

Sep 30 2020n/an/a

-US$134m

Jun 30 2020n/an/a

-US$78m

Mar 31 2020n/an/a

-US$49m

Dec 31 2019US$2mUS$394k

-US$31m

Sep 30 2019n/an/a

-US$100m

Jun 30 2019n/an/a

-US$105m

Mar 31 2019n/an/a

-US$105m

Dec 31 2018US$1mUS$366k

-US$112m

보상 대 시장: Serge 의 총 보상 ($USD 8.29M )은 US 시장( $USD 5.67M ).

보상과 수익: Serge 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Serge Saxonov (47 yo)

11.9yrs

테뉴어

US$8,286,050

보상

Dr. Serge Saxonov, Ph D, Co-Founded 10X Genomics, Inc. and has been its Chief Executive Officer and Director since July 2012. Prior to 10x Genomics, Dr. Saxonov was Vice President of Applications at Quanta...

리더십 팀

이름위치테뉴어보상소유권
Serge Saxonov
Co-Founder11.9yrsUS$8.29m3.36%
$ 80.2m
Benjamin Hindson
Co-Founder11.9yrsUS$4.43m2.69%
$ 64.4m
Justin McAnear
Chief Financial Officer5.7yrsUS$3.31m0.047%
$ 1.1m
Eric Whitaker
Chief Legal Officer6.9yrsUS$3.88m0.12%
$ 2.8m
Michael Schnall-Levin
Founding Scientist & CTO2.4yrs데이터 없음데이터 없음
Cassie Corneau
Manager of Investor Relations and Strategic Financeno data데이터 없음데이터 없음
Rebecca Port
Chief People Officer3.4yrs데이터 없음데이터 없음
Jens Durruthy
Associate Director of Product Managementno data데이터 없음데이터 없음

6.3yrs

평균 재임 기간

48.5yo

평균 연령

경험이 풍부한 관리: TXG 의 관리팀은 노련하고 경험 (평균 재직 기간 6.3 년)입니다.

이사회 구성원

이름위치테뉴어보상소유권
Serge Saxonov
Co-Founder11.9yrsUS$8.29m3.36%
$ 80.2m
Benjamin Hindson
Co-Founder11.9yrsUS$4.43m2.69%
$ 64.4m
Kimberly Popovits
Independent Director4.3yrsUS$338.71k0.0039%
$ 92.0k
John Stuelpnagel
Independent Chairman10.8yrsUS$403.59k2.04%
$ 48.7m
Shehnaaz Suliman
Independent Director4.8yrsUS$336.39k0.0039%
$ 92.0k
Mathai Mammen
Independent Director6.8yrsUS$331.39k0.14%
$ 3.4m
Sridhar Kosaraju
Independent Director5.2yrsUS$346.39k0.030%
$ 707.5k

6.8yrs

평균 재임 기간

52yo

평균 연령

경험이 풍부한 이사회: TXG 의 이사회는 경험(평균 재직 기간 6.8 년)으로 간주됩니다.